NTLA-2001
Intellia Therapeutics
['cardio', 'cardiomyopathy']
novel gene-editing therapy shows promise for patients with transthyretin amyloid cardiomyopathy #aha22 
HeartNews delivers the latest news, information and resources about heart disease and stroke from the American Heart Association/American Stroke Association.